.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Analyze global market entry opportunities
  • Find suppliers and generic API sources

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
UBS
Merck
Boehringer Ingelheim
Dow
Fish and Richardson
Argus Health
Deloitte
QuintilesIMS
Cantor Fitzgerald

Generated: June 23, 2017

DrugPatentWatch Database Preview

THEOPHYL Drug Profile

« Back to Dashboard

Which patents cover Theophyl, and when can generic versions of Theophyl launch?

Theophyl is a drug marketed by Ortho Mcneil Pharm, Alpharma Us Pharms, Pliva, Pharm Assoc, Taro, Alembic Pharms Ltd, Scherer Rp, Hospira, Inwood Labs, Teva Pharms, Roxane, Able, Wockhardt, Chartwell Rx, Cent Pharms, Glenmark Generics, Silarx, Mylan Ireland Ltd, Sandoz, Kv Pharm, Precision Dose, Halsey, Rhodes Pharms, Cenci, Tris Pharma Inc, B Braun, Baxter Hlthcare, and Hospira Inc. and is included in forty-nine NDAs.

The generic ingredient in THEOPHYL is theophylline. There are thirty-six drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the theophylline profile page.

Summary for Tradename: THEOPHYL

Patents:0
Applicants:28
NDAs:49
Bulk Api Vendors: see list84
Patent Applications: see list9,683
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:THEOPHYL at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira Inc
THEOPHYLLINE IN DEXTROSE 5% IN PLASTIC CONTAINER
theophylline
INJECTABLE;INJECTION019211-007Dec 14, 1984APRXYesYes► Subscribe► Subscribe
Kv Pharm
THEOPHYLLINE
theophylline
CAPSULE;ORAL085263-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Inwood Labs
THEOPHYLLINE
theophylline
CAPSULE, EXTENDED RELEASE;ORAL040052-004Feb 14, 1994DISCNNoNo► Subscribe► Subscribe
Cenci
THEOPHYLLINE
theophylline
ELIXIR;ORAL087679-001Apr 15, 1982DISCNNoNo► Subscribe► Subscribe
B Braun
THEOPHYLLINE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER
theophylline
INJECTABLE;INJECTION019826-004Aug 14, 1992DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Teva
Harvard Business School
Federal Trade Commission
Accenture
Chubb
Merck
Express Scripts
UBS
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot